Zotefoams Plc · LSE:ZTF

Zotefoams — H1 2016 Earnings Presentation

43 slides from Zotefoams's earnings presentation, August 2016

  1. Slide 1: Half Year Results 2016

    Half Year Results 2016 David Stirling: Group CEO Gary McGrath: Finance Director

  2. Slide 2: Important notice

    Important notice By attending the meeting where this presentation is made, or by reading the presentation slides, you agree to be bound by the following limitations: This presentation is being made only in the United Kingdom and this document is being distributed only to and is directed only at pers

  3. Slide 3: Six months to 30 June 2016 Summary

    Six months to 30 June 2016 Summary

  4. Slide 4: Highlights

    Highlights 2% increase in Interim dividend Group Revenue increased by to £27.07m 3% to 1.85 (2015: £26.49m) pence Operating profit Positive sales pre-exceptional momentum items increased A world leader in cellular going into by 5% materials technology second half of 2016 Adjusted profit Group focus

  5. Slide 5: Contents

    Contents Zotefoams is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen gas expansion, Zotefoams produces lightweight foams in UK and USA for diverse markets worldwide. Zotefoams also owns and licenses patented MuCell® microc

  6. Slide 6: Group Overview - Locations

    Group Overview - Locations Zotefoams Plc MuCell Extrusion HQ Zotefoams Midwest Croydon UK Woburn, MA, USA Tulsa, OK, USA AZOTE® and ZOTEK® Licences MuCell Foam cutting technology to end users block foam manufacturing site Zotefoams Inc AZOTE AZOTE Asia Limited Walton, KY, USA Hong Kong AZOTE® block

  7. Slide 7: Group Overview

    Group Overview Revenue by Geography Revenue By Business Unit Polyolefins HPP MEL £millions 10% 21% 40% June -15 29% June -16 Continental Europe North America United Kingdom & Eire RoW - 5.0 10.0 15.0 20.0 25.0 30.0 Revenue by Industry 35% 30% Business Units 30% Business Units 25% 24% Polyolefin Foam

  8. Slide 8: Zotefoams' Strategy

    ZOTEFOAMS Zotefoams’ Strategy 7 Zotefoams’ strategy is to expand through a combination of profitable organic growth of our AZOTE® and HPP foams businesses, new customers for our MuCell® extrusion-technology licensing business, and through partnerships or acquisitions in related technologies, product

  9. Slide 9: Contents

    Contents 1. Group Overview 2. Results 3. Business Review Appendices Page : 9

  10. Slide 10: Income Statement

    Income Statement £ million June-16 June-15 % Change Group Revenue 27.07 26.49 2% Gross Profit 8.14 7.94 2% Distribution and admin expenses1 (5.31) (4.33) (23%) FX translation gains/(losses) 0.51 (0.44) Operating Profit before exceptional item 3.33 3.17 5% Net Interest/Joint Venture Loss (0.31) (0.16

  11. Slide 11: Polymer (LDPE) Prices

    Polymer (LDPE) Prices 1800 1600 1,392 1400 1,240 1200 €/tonne 1000 800 600 400 200 0 P&L Cost Spot Price • P&L impact up 15% Y-on-Y at the half year Page : 11

  12. Slide 12: Free Cash Flow

    Free Cash Flow £ million June-16 June-15 Operating profit (pre exceptional item) 3.33 3.17 Depreciation, impairment & amortisation 1.78 1.73 Working capital 0.34 0.28 Pension contributions (0.33) (0.33) Other (0.18) 0.14 Cash generated from operations 4.93 4.99 Tax & interest paid (0.82) (0.41) Net

  13. Slide 13: Cash Flow and Net Debt

    Cash Flow and Net Debt £ million June-16 June-15 Free cash (out)/inflow (3.89) 1.22 Repayment of borrowings (0.46) (0.38) Dividends (1.66) (1.62) £ million June-16 June-15 Other 0.29 (0.14) Net (debt)/cash (0.32) 3.71 Net cash used (5.59) (0.92) Borrowings (6.91) (1.85) Net (debt)/cash (7.23) 1.86 N

  14. Slide 14: Balance Sheet

    Balance Sheet £ million June-16 June-15 Investments in joint venture 0.16 0.34 Intangible assets 7.22 6.79 Tangible assets 41.98 29.78 Net working capital 16.91 16.50 Retirement benefit obligations (7.62) (5.91) Deferred tax, net 0.17 (0.40) Tax payable (0.44) (0.49) Net (debt)/cash (7.23) 1.86 Tota

  15. Slide 15: Contents

    Contents 1. Group Overview 2. Results 3. Business Review Appendices Page : 15

  16. Slide 16: Zotefoams

    | YQ ZOTEFOAMS

  17. Slide 17: AZOTE Polyolefin Foams

    AZOTE® Polyolefin Foams High quality foams from a variety base polymers all manufactured using the same nitrogen expansion process Structure: AZOTE® Polyolefin Zotefoams has foams are largest market consistent, share in UK, EU lightweight & pure and North AZOTE® foams Process: core American markets

  18. Slide 18: AZOTE Polyolefin Foams

    AZOTE® Polyolefin Foams High quality foams from a variety of base polymers all manufactured using the same nitrogen expansion process Sales growth of Product line AZOTE® foams to extension in specific exceed twice the sub-segments, where average rate of Zotefoams has a global GDP growth lower market

  19. Slide 19: AZOTE Polyolefin Foams: Results

    AZOTE® Polyolefin Foams: Results Revenue • Underlying volume estimated +4% offset by customer destocking • Strong performance in UK +9% Polyolefin Foams June-16 June-15 % • Continental EU volumes -5% £m £m Change • Asia volumes -25% Group Revenue 22.79 22.09 3% • North America +9% volume with added

  20. Slide 20: HPP

    | X ZOTEFOAMS

  21. Slide 21: HPP: ZOTEK and T-FIT

    HPP: ZOTEK® and T-FIT® High performance foams manufactured from advanced materials ZOTEK® HPP foams T-FIT® advanced are manufactured from insulation raw materials offering manufactured from enhanced properties ZOTEK polymers Properties: fire Process: core high- retardant or having pressure nitrogen

  22. Slide 22: HPP: ZOTEK & T-FIT

    HPP: ZOTEK® & T-FIT® High performance foams manufactured from advanced materials ZOTEK® F Increase fluoroploymer Penetration of foams for aviation existing market remains the largest such as aviation & market clean-room ZOTEK® PEBA insulation energy New management Opportunities foams primarily for r

  23. Slide 23: HPP Results: Sales History

    HPP Results: Sales History 12 months ended 30 June 9,000 8,000 7,000 6,000 5,000 £000s Jan to June 4,000 July to Dec 3,000 2,000 1,000 - 2009 2010 2011 2012 2013 2014 2015 2016 Page : 23

  24. Slide 24: HPP Results

    HPP Results HPP June-16 June-15 % Change Revenue £m £m • H1:2016 sales impacted due to timing Group Revenue 3.17 3.39 (7%) • 12 months to 30 June 2016 2016 £8,046k (2015: £7,251k), 11% growth Segment profit pre- 0.30 0.67 (55%) • Strong second half with full year 2016 amortisation “orders + invoiced

  25. Slide 25: MuCell

    MUCELL® | YQ ZOTEFOAMS

  26. Slide 26: MuCell Extrusion Business Model

    MuCell Extrusion Business Model MUCELL® technology is a remarkable patented process that creates “micro-bubbles” in the core of plastic parts or products Process: easy to MEL licenses retrofit to existing technology for equipment. Uses continuous foaming CO2 or nitrogen. Both are inert, environmenta

  27. Slide 27: MuCell Extrusion

    MuCell Extrusion MUCELL® technology is a remarkable patented process that creates “micro-bubbles” in the core of plastic parts or products Focus of activities towards a limited number of segments Machinery sales with high potential, are enabling mainly in consumer technology packaging Consumer Strat

  28. Slide 28: MuCell Extrusion: Results

    MuCell Extrusion: Results MEL June-16 June-15 % Revenue £m £m Change Group Revenue 1.11 1.01 10% • Further 11 lines installed at licensees bringing total installed base to 99 Segment loss pre (0.24) (0.22) (9%) • Co-operation with The Dow Chemical amortisation Company related to 2016 Rio Olympic Amo

  29. Slide 29: MuCell Extrusion: Equipment Base

    MuCell Extrusion: Equipment Base 2015 as at 31/12/2015, 2016 as at 30/06/2016 21 16 10 13 14 14 19 20 3 4 12 12 9 9 5 6 FILM FILM BLOW BLOW SHEET SHEET SPECIALITY SPECIALITY 2015 2016 MOULDING MOULDING 2015 2016 2015 2016 2015 2016 Units in use Units not in use Page : 29

  30. Slide 30: Business Review: Other

    Business Review : Other | X ZOTEFOAMS

  31. Slide 31: Group Investment

    Group Investment Autoclave technology used for both AZOTE® and ZOTEK® foams. Investment in Kentucky & Croydon capacity based on demand expectations. Kentucky, USA investment in capacity scheduled for commissioning H1:2017 New sites in Oklahoma, USA operational. Kunshan, PRC expected to be operationa

  32. Slide 32: NEW - 3D Foaming

    NEW - 3D Foaming FLEXIBLE AND EFFICIENT TECHNOLOGY FOR HIGH-VOLUME 3D SHAPES UNIQUE TECHNOLOGY ENHANCEMENT • 3D foaming of the initial non-foamed shape allows efficient utilisation of raw materials and reduction (or elimination) of processing after the foaming step. • Particularly suited to higher-c

  33. Slide 33: Kentucky, USA Investment

    Kentucky, USA Investment GLOBAL CAPACITY INVESTMENT EXPANSION IN GROUP ON EXISTING CAPACITY FREEHOLD TO SUPPORT GROWTHSITE FURTHER INVESTMENT & REAFFIRMATION OF PLANNED START-UP Project scale extension by adding a second high-pressure autoclave • Underpins investment in KY site • Ability to deliver

  34. Slide 34: Capex Investment

    Capex Investment An international business delivering significant growth through organic expansion and leverage of our unique technologies INVESTMENT TO SUPPORT GROWTH £0.90 • Investment over 4 sites globally £1.10 • Kentucky, USA main focus • Two business start ups £4.10 £0.40 • UK balance of capac

  35. Slide 35: Current Trading and Prospects

    Current Trading and Prospects In our AZOTE® Polyolefin foams business, where customers are predominantly based in the UK and continental Europe, the softening of orders experienced in June 2016 has continued into July 2016, whereas demand for August 2016 looks strong by comparison to previous years.

  36. Slide 36: Outlook

    Outlook We enter the second half of the year with a good order book, a strong product portfolio, growth expectations in all business units and the benefits of the weaker Sterling. Whilst recognising the significant uncertainty resulting from the macro-economic backdrop, the Board remains confident i

  37. Slide 37: Appendices

    Appendices | X ZOTEFOAMS

  38. Slide 38: Zotefoams Process

    Zotefoams Process Stage 1: High quality extrusion and cross-linking of solid polymeric sheet Base resin and additive ingredients are fed into an extruder. This produces a wide, continuous sheet of crosslinked plastic, from which precise size slabs are cut. Page : 38

  39. Slide 39: Zotefoams Process

    Zotefoams Process Stage 2: Impregnation and saturation The extruded slabs are loaded into a high pressure autoclave. The plastic is heated above its softening temperature and subjected to a high pressure dose of pure nitrogen. Page : 39

  40. Slide 40: Zotefoams Process

    Zotefoams Process Stage 3: Expansion The nitrogen charged slabs are loaded into a low pressure autoclave. The material is again heated above its softening temperature under a moderate air pressure; then the pressure is removed. Without the pressure, the nitrogen expands, physically foaming the soft

  41. Slide 41: Value Chain / Strategy

    Value Chain / Strategy Page : 41

  42. Slide 42: Financial History

    Financial History Actual Actual Actual Actual Actual Actual Actual Actual Actual Actual £million 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Group Revenue 53.9 48.9 44.6 47.2 44.2 39.9 31.8 34.8 31.6 30.1 Revenue Growth 10% 10% (6%) 7% 11% 25% (9%) 10% 5% 7% PBT (excl exceptionals) 6.0 5.3 3.9

  43. Slide 43: Market Information

    Market Information Share price 265.0p (29/07/16) Market Main Market Ticker ZTF.L Shareholder Profile* Market cap. £117.7m Ord. shares in issue 44,414,440 380 1,000 360 900 800 340 700 Traded volume ('000s) 320 Share price (p) 600 300 500 280 400 260 300 240 Miton 13.9% BlackRock 13.6% 200 Schroders

Zotefoams — H1 2016 Earnings Presentation on 6ix